Annual Long Term Debt
$47.55 M
+$45.53 M+2249.56%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual long term debt is currently $47.55 million, with the most recent change of +$45.53 million (+2249.56%) on 31 December 2023. During the last 3 years, it has risen by +$44.48 million (+1447.01%). CRNX annual long term debt is now at all-time high.CRNX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$45.13 M
-$747.00 K-1.63%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly long term debt is currently $45.13 million, with the most recent change of -$747.00 thousand (-1.63%) on 30 September 2024. Over the past year, it has dropped by -$2.43 million (-5.11%). CRNX quarterly long term debt is now -6.34% below its all-time high of $48.18 million, reached on 30 September 2023.CRNX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -5.1% |
| 3 y3 years | +1447.0% | +1368.0% |
| 5 y5 years | +880.7% | +830.6% |
CRNX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2249.6% | -6.3% | +2999.3% |
| 5 y | 5 years | at high | +2249.6% | -6.3% | +2999.3% |
| alltime | all time | at high | -6.3% |
Crinetics Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $45.13 M(-1.6%) |
| June 2024 | - | $45.87 M(-1.8%) |
| Mar 2024 | - | $46.71 M(-1.8%) |
| Dec 2023 | $47.55 M(+2249.6%) | $47.55 M(-1.3%) |
| Sept 2023 | - | $48.18 M(+3209.2%) |
| June 2023 | - | $1.46 M(-16.5%) |
| Mar 2023 | - | $1.74 M(-13.9%) |
| Dec 2022 | $2.02 M(-34.2%) | $2.02 M(-12.0%) |
| Sept 2022 | - | $2.30 M(-10.3%) |
| June 2022 | - | $2.56 M(-9.1%) |
| Mar 2022 | - | $2.82 M(-8.2%) |
| Dec 2021 | $3.07 M | $3.07 M(-7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $3.32 M(-6.6%) |
| June 2021 | - | $3.56 M(-6.1%) |
| Mar 2021 | - | $3.79 M(-5.6%) |
| Dec 2020 | $4.01 M(-17.2%) | $4.01 M(-5.2%) |
| Sept 2020 | - | $4.23 M(-4.7%) |
| June 2020 | - | $4.44 M(-4.4%) |
| Mar 2020 | - | $4.65 M(-4.1%) |
| Dec 2019 | $4.85 M(>+9900.0%) | $4.85 M(-3.9%) |
| Sept 2019 | - | $5.04 M(-3.5%) |
| June 2019 | - | $5.23 M(-3.2%) |
| Mar 2019 | - | $5.40 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00 |
| Dec 2016 | $163.00 K | - |
FAQ
- What is Crinetics Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly long term debt year-on-year change?
What is Crinetics Pharmaceuticals annual long term debt?
The current annual long term debt of CRNX is $47.55 M
What is the all time high annual long term debt for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual long term debt is $47.55 M
What is Crinetics Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of CRNX is $45.13 M
What is the all time high quarterly long term debt for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly long term debt is $48.18 M
What is Crinetics Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, CRNX quarterly long term debt has changed by -$2.43 M (-5.11%)